Kemper M - Search Results

1

Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.

Bischoff P, Reck M, Overbeck T, Christopoulos P, Rittmeyer A, Lüders H, Kollmeier J, Kulhavy J, Kemper M, Reinmuth N, Röper J, Janning M, Sommer L, Aguinarte L, Koch M, Wiesweg M, Wesseler C, Waller CF, Kauffmann-Guerrero D, Stenzinger A, Stephan-Falkenau S, Trautmann M, Lassmann S, Tiemann M, Klauschen F, Sebastian M, Griesinger F, Wolf J, Loges S, Frost N; National Network Genomic Medicine Lung Cancer (nNGM) Collaborator Group. Bischoff P, et al. Among authors: kemper m. J Thorac Oncol. 2024 May;19(5):803-817. doi: 10.1016/j.jtho.2023.12.015. Epub 2023 Dec 13. J Thorac Oncol. 2024. PMID: 38096950 Free article.

2

PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.

Schöne N, Kemper M, Menck K, Evers G, Krekeler C, Schulze AB, Lenz G, Wardelmann E, Binder C, Bleckmann A. Schöne N, et al. Among authors: kemper m. J Extracell Vesicles. 2024 Mar;13(3):e12418. doi: 10.1002/jev2.12418. J Extracell Vesicles. 2024. PMID: 38453684 Free PMC article.

3

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with focus on perioperative therapy, radiotherapy and BiTEs.

Kemper M, Soltani Germy P, Acker F, Luan J, Griesinger F, Tufman A, Kropf-Sanchen C, Overbeck TR, Bleckmann A, Blasi M. Kemper M, et al. Oncol Res Treat. 2024 Apr 4. doi: 10.1159/000538662. Online ahead of print. Oncol Res Treat. 2024. PMID: 38574467 No abstract available.

4

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A. Kemper M, et al. Oncotarget. 2021 Sep 14;12(19):1946-1952. doi: 10.18632/oncotarget.28062. eCollection 2021 Sep 14. Oncotarget. 2021. PMID: 34548910 Free PMC article.

5

Liquid Biopsies in Lung Cancer.

Kemper M, Krekeler C, Menck K, Lenz G, Evers G, Schulze AB, Bleckmann A. Kemper M, et al. Cancers (Basel). 2023 Feb 23;15(5):1430. doi: 10.3390/cancers15051430. Cancers (Basel). 2023. PMID: 36900221 Free PMC article. Review.

6

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with focus on targeted therapies.

Acker F, Luan J, Soltani Germy P, Kemper M, Blasi M, Griesinger F, Tufman A, Bleckmann A, Kropf-Sanchen C, Overbeck TR. Acker F, et al. Among authors: kemper m. Oncol Res Treat. 2024 Mar 25. doi: 10.1159/000538436. Online ahead of print. Oncol Res Treat. 2024. PMID: 38527447 No abstract available.

7

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A. Kemper M, et al. Oncotarget. 2022 Nov 2;13:1216. doi: 10.18632/oncotarget.28293. Oncotarget. 2022. PMID: 36342457 Free PMC article. No abstract available.

8

Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario.

Krekeler C, Reitnauer L, Bacher U, Khandanpour C, Steger L, Boeckel GR, Klosner J, Tepasse PR, Kemper M, Hennies MT, Mesters R, Stelljes M, Schmitz N, Kerkhoff A, Schliemann C, Mikesch JH, Schmidt N, Lenz G, Bleckmann A, Shumilov E. Krekeler C, et al. Among authors: kemper m. Cancers (Basel). 2022 Nov 9;14(22):5512. doi: 10.3390/cancers14225512. Cancers (Basel). 2022. PMID: 36428605 Free PMC article.

9

Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient.

Kemper M, Lenz G, Mesters RM. Kemper M, et al. Acta Haematol. 2022;145(2):210-213. doi: 10.1159/000519451. Epub 2021 Oct 6. Acta Haematol. 2022. PMID: 34614491 Free PMC article.

10

Favorable Outcome After Single-kidney Transplantation From Small Donors in Children: A Match-controlled CERTAIN Registry Study.

Schild R, Carvajal Abreu K, Büscher A, Kanzelmeyer N, Lezius S, Krupka K, Weitz M, Prytula A, Printza N, Berta L, Saygılı SK, Sellier-Leclerc AL, Spartà G, Marks SD, Kemper MJ, König S, Topaloglu R, Müller D, Klaus G, Weber S, Oh J, Herden U, Carraro A, Dello Strologo L, Ariceta G, Hoyer P, Tönshoff B, Pape L. Schild R, et al. Among authors: kemper mj. Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000004993. Online ahead of print. Transplantation. 2024. PMID: 38685197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

442 results

Search Page